Back to search

United States· US:76472-4100_2dcc654b-c827-d596-e063-6294a90a53bc

12 CELL SALTS COMPLEX

A medicinal product containing dibasic potassium phosphate; silicon dioxide; calcium sulfate anhydrous; ferrosoferric phosphate; sodium phosphate, dibasic, heptahydrate; calcium fluoride; potassium chloride; magnesium phosphate, dibasic trihydrate; sodium sulfate; sodium chloride; tribasic calcium phosphate; potassium sulfate, registered in United States by SEVENE USA.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalised12 CELL SALTS COMPLEXATC—REGISTER NO.US:76472-4100_2dcc654…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DIBASIC POTASSIUM PHOSPHATE; SILICON DIOXIDE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; CALCIUM FLUORIDE; POTASSIUM CHLORIDE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; SODIUM SULFATE; SODIUM CHLORIDE; TRIBASIC CALCIUM PHOSPHATE; POTASSIUM SULFATE
Manufacturer
SEVENE USA
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    7647241001
    80 PELLET in 1 CYLINDER (76472-4100-1)
  • ndc11
    76472-4100-1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/83debb94-2d10-440e-a48b-aba5b4f19579
GET /v1/drugs/83debb94-2d10-440e-a48b-aba5b4f19579?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "SUBLINGUAL",
  "source": "ndc",
  "strength": "6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6",
  "substance": "DIBASIC POTASSIUM PHOSPHATE; SILICON DIOXIDE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; CALCIUM FLUORIDE; POTASSIUM CHLORIDE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; SODIUM SULFATE; SODIUM CHLORIDE; TRIBASIC CALCIUM PHOSPHATE; POTASSIUM SULFATE",
  "productndc": "76472-4100",
  "dosage_form": "PELLET",
  "dea_schedule": null,
  "strength_unit": "[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1",
  "application_number": null,
  "marketing_category": "UNAPPROVED HOMEOPATHIC"
}

See everything about dibasic potassium phosphate; silicon dioxide; calcium sulfate anhydrous; ferrosoferric phosphate; sodium phosphate, dibasic, heptahydrate; calcium fluoride; potassium chloride; magnesium phosphate, dibasic trihydrate; sodium sulfate; sodium chloride; tribasic calcium phosphate; potassium sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.